Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

INSYS Therapeutics Inc (NASDAQ:INSY)

17.93
BATS BZX Real-Time Price
As of 10:26am ET
 +1.56 / +9.53%
Today’s Change
11.45
Today|||52-Week Range
37.19
-37.37%
Year-to-Date
2 Big Back-Alley Brawls Break Out in Washington Over Policy
Aug 23 / MotleyFool.com - Paid Partner Content
Did the DEA Just Give These Marijuana Companies a Big Break?
Aug 13 / MotleyFool.com - Paid Partner Content
Insys Therapeutics Starts Enrollment in Cannabidiol Trial
Aug 19 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close16.37
Today’s open17.59
Day’s range17.40 - 18.38
Volume40,455
Average volume (3 months)699,484
Market cap$1.2B
Dividend yield--
Data as of 10:26am ET, 08/24/2016

Growth & Valuation

Earnings growth (last year)+48.08%
Earnings growth (this year)-74.15%
Earnings growth (next 5 years)+28.00%
Revenue growth (last year)+48.92%
P/E ratio27.9
Price/Sales6.55
Price/Book4.64

Competitors

 Today’s
change
Today’s
% change
ACORAcorda Therapeutics ...+0.08+0.31%
LCILannett Company Inc+5.05+15.62%
CEMPCempra Inc+0.20+0.88%
DERMDermira Inc+0.43+1.27%
Data as of 10:26am ET, 08/24/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)$0.07
Annual revenue (last year)$330.8M
Annual profit (last year)$58.5M
Net profit margin17.68%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
John N. Kapoor
Chief Financial &
Accounting Officer
Darryl S. Baker
Corporate headquarters
Chandler, Arizona

Forecasts

Partner Offers

Search for Jobs